Bioventures is an opportunity for trainees (those pursuing PhDs, MDs, residency, post-docs, MBAs, undergraduates etc.) engage in a hands on entrepreneurship experience by turning their life science/biotech/medtech ideas into a refined investor pitch deck. The program combines lecture based learning with weekly pitch practice and feedback sessions.
Bioventures alumni have developed 8 companies in the program and have founded 5 other companies after participation. Prior areas of focus include diagnostics, therapeutics, medical devices, and direct to consumer life science products. Collectively alumni have raised $5M+ and have participated in incubators/accelerators including Y Combinator, Mass Challenge, Station Houston, JLABS, and TMCx.
Prior participants have joined us from Rice, BCM, UTMB, Lamar, UT Health, TAMU, UH, MD Anderson, etc. Trainees must be willing to commit 10+ hours per week from June 3 – August 5 to participate in the program. If you are interested in participating, please fill out our signup form. Contact Manwal Harb (firstname.lastname@example.org) for any questions.
Bioventures 2021 runs Thursday evenings June through August.
May 15: Team Formation Day- Pitch your technology or value as a teammate. The best ideas will be identified by mentors and teams will form around these ideas.
June 3 - August 5: Sessions: Hour 1 will be a guest lecture and hours 2-3 will be team pitches with feedback
August 14: Final Pitch Day
In this episode, we speak with Dr. Elizabeth Jaworski, founder and CEO of ClickSeq Technologies, a next generation sequencing service that is simple and affordable.
Enventure Insights provides analysis on COVID-19 vaccines, performing diligence on SARS-CoV-2 data and the global response, as well as an assessment of the competitive landscape and market trends.